• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆管癌的非手术治疗。40例回顾性分析。

Nonsurgical management of primary cholangiocarcinoma. Retrospective analysis of 40 cases.

作者信息

Banerjee B, Teplick S K

机构信息

Department of Medicine, University of Arkansas for Medical Sciences, Little Rock 72205.

出版信息

Dig Dis Sci. 1995 Mar;40(3):701-5. doi: 10.1007/BF02064393.

DOI:10.1007/BF02064393
PMID:7534679
Abstract

Forty patients with cholangiocarcinoma (23 men, 17 women) underwent nonsurgical palliative biliary drainage over a period of 12 years. All were surgically unfit or had unresectable disease. All were jaundiced at presentation with a mean serum bilirubin of 11.5 +/- 1.9 mg/dl. Thirty patients (75%) had hilar obstruction. Twenty-eight were drained percutaneously, three endoscopically and nine by a combined endoscopic and percutaneous procedure. Technical success was 97.5%. Final mean bilirubin was 1.5 +/- 0.4 mg/dl. Minor complications occurred in 10 (25%) patients, and major complications in four (10%). Procedure-related mortality was 2.5% with a 30-day mortality of 7.5%. Mean survival was 8.2 +/- 0.5 months. Stent changes were required in eight patients. In patients with inoperable or unresectable cholangiocarcinoma, percutaneous or endoscopic biliary drainage offers effective palliation.

摘要

40例胆管癌患者(23例男性,17例女性)在12年期间接受了非手术姑息性胆道引流。所有患者均不适合手术或患有不可切除的疾病。所有患者就诊时均有黄疸,平均血清胆红素为11.5±1.9mg/dl。30例患者(75%)有肝门部梗阻。28例患者接受了经皮引流,3例接受了内镜引流,9例接受了内镜和经皮联合引流。技术成功率为97.5%。最终平均胆红素为1.5±0.4mg/dl。10例患者(25%)发生轻微并发症,4例患者(10%)发生严重并发症。与操作相关的死亡率为2.5%,30天死亡率为7.5%。平均生存期为8.2±0.5个月。8例患者需要更换支架。对于无法手术或不可切除的胆管癌患者,经皮或内镜胆道引流可提供有效的姑息治疗。

相似文献

1
Nonsurgical management of primary cholangiocarcinoma. Retrospective analysis of 40 cases.原发性胆管癌的非手术治疗。40例回顾性分析。
Dig Dis Sci. 1995 Mar;40(3):701-5. doi: 10.1007/BF02064393.
2
Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.晚期III型或IV型肝门部胆管癌患者使用自膨式金属支架的姑息治疗:经皮途径与内镜途径的比较
Gastrointest Endosc. 2009 Jan;69(1):55-62. doi: 10.1016/j.gie.2008.04.005. Epub 2008 Jul 26.
3
Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction.经皮金属支架置入术姑息治疗恶性肝门部胆管梗阻。
Korean J Radiol. 2018 Jul-Aug;19(4):597-605. doi: 10.3348/kjr.2018.19.4.597. Epub 2018 Jun 14.
4
[Percutaneous self-expanding metallic endoprosthesis and malignant biliary stenoses].[经皮自膨式金属内支架与恶性胆管狭窄]
J Radiol. 1998 Jan;79(1):39-43.
5
Feasibility and complications of endoscopic biliary drainage in patients with malignant biliary obstruction at King Chulalongkorn Memorial Hospital.朱拉隆功国王纪念医院恶性胆管梗阻患者内镜下胆管引流的可行性及并发症
J Med Assoc Thai. 2002 Jun;85 Suppl 1:S48-53.
6
Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.使用自膨式金属支架对恶性肝门部胆管梗阻进行选择性磁共振胰胆管造影(MRCP)和CT引导下引流
Gastrointest Endosc. 2003 Jul;58(1):41-9. doi: 10.1067/mge.2003.292.
7
Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study.Y形内镜下双侧金属支架置入术治疗恶性肝门部胆管梗阻:前瞻性长期研究
Scand J Gastroenterol. 2011 Mar;46(3):326-32. doi: 10.3109/00365521.2010.536253. Epub 2010 Nov 17.
8
Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage.晚期肝门部胆管肿瘤患者接受姑息性内镜或经皮引流的长期预后
Z Gastroenterol. 2000 Jun;38(6):483-9. doi: 10.1055/s-2000-14886.
9
Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinoma.与经皮胆道引流治疗肝门部胆管癌短期疗效相关的因素。
World J Gastroenterol. 2009 Nov 7;15(41):5206-10. doi: 10.3748/wjg.15.5206.
10
Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence.肝内胆管肠内吻合术可为肝管汇合处恶性梗阻的特定患者提供有效的姑息治疗。
Am J Surg. 1998 Jun;175(6):453-60. doi: 10.1016/s0002-9610(98)00084-1.

引用本文的文献

1
Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma.胆汁碱性磷酸酶在非黄疸型胆管癌中的临床价值
J Cancer Res Clin Oncol. 2004 Feb;130(2):87-92. doi: 10.1007/s00432-003-0515-x. Epub 2003 Nov 28.
2
Diagnosis, Staging, and Treatment of Cholangiocarcinoma.胆管癌的诊断、分期及治疗
Curr Treat Options Gastroenterol. 2003 Apr;6(2):105-112. doi: 10.1007/s11938-003-0011-z.
3
Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

本文引用的文献

1
Carcinoma of the extrahepatic bile ducts; review of the literature and report of six cases.肝外胆管癌;文献综述及6例报告
Surgery. 1957 Mar;41(3):416-37.
2
Symptom relief and quality of life after stenting for malignant bile duct obstruction.恶性胆管梗阻支架置入术后的症状缓解与生活质量
Gut. 1994 Apr;35(4):467-70. doi: 10.1136/gut.35.4.467.
3
Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer.东部肿瘤协作组针对无法手术切除的胆囊癌和胆管癌进行化疗的经验。
肝脏肝内胆管细胞癌中p53肿瘤抑制基因的突变、细胞凋亡与增殖
Dig Dis Sci. 2000 Feb;45(2):317-24. doi: 10.1023/a:1005412626515.
4
Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.磁共振胰胆管造影在恶性肝门部狭窄分期中的性能特征
Gut. 2000 Jan;46(1):103-6. doi: 10.1136/gut.46.1.103.
5
Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction.恶性胆管梗阻经皮经肝胆道引流术后的菌血症和胆管炎
Dig Dis Sci. 1999 Mar;44(3):542-6. doi: 10.1023/a:1026653306735.
6
[Palliative therapy of carcinomas of the biliary system].
Med Klin (Munich). 1997 Jul 15;92(7):401-5. doi: 10.1007/BF03042570.
Cancer. 1984 Sep 15;54(6):965-9. doi: 10.1002/1097-0142(19840915)54:6<965::aid-cncr2820540603>3.0.co;2-x.
4
Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts.肝管汇合处胆管癌的手术治疗方法
Lancet. 1984 Jan 14;1(8368):66-70. doi: 10.1016/s0140-6736(84)90002-3.
5
Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts.肝外胆管癌根治性手术的评估
Ann Surg. 1980 Jan;191(1):23-9. doi: 10.1097/00000658-198001000-00005.
6
Intrahepatic bile duct carcinoma and C. sinensis infection in Hong Kong.香港的肝内胆管癌与华支睾吸虫感染
Cancer. 1973 Feb;31(2):468-73. doi: 10.1002/1097-0142(197302)31:2<468::aid-cncr2820310226>3.0.co;2-j.
7
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients.肝胆纤维多囊性疾病。51例患者的临床与组织学回顾
J Hepatol. 1986;2(2):141-56. doi: 10.1016/s0168-8278(86)80073-3.
8
Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study.华支睾吸虫感染与胆管癌。一项前瞻性病例对照研究。
Gastroenterology. 1985 Jul;89(1):151-6. doi: 10.1016/0016-5085(85)90755-3.
9
Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.
Virchows Arch A Pathol Anat Histopathol. 1985;406(1):45-58. doi: 10.1007/BF00710556.
10
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer.
World J Surg. 1988 Feb;12(1):68-77. doi: 10.1007/BF01658489.